EP MONEY

India’s artificial intelligence ecosystem has a new unicorn. Bengaluru-based Sarvam AI has raised $234 million in the first close of its Series B funding round, taking its valuation to $1.5 billion and cementing its position as one of the country’s most prominent AI startups. The round was led by HCLTech and Bessemer Venture Partners, with […]

India’s car insurance industry is grappling with a fundamental transparency problem that affects millions of vehicle owners. Insurance companies have quietly shifted their position on E20 fuel use in older cars, but the change masks a deeper coverage problem buried in policy fine print. E20 is a petrol blend containing 20 percent ethanol, introduced by

The United States has announced a deal to end its conflict with Iran, but consumers should not expect fuel prices to drop immediately. Energy analysts warn that petrol and diesel prices will remain higher than normal for several months, even after the agreement is implemented. The reason is straightforward: the global oil market cannot adjust

Indian electronics manufacturers are facing one of their biggest supply chain disruptions in recent months as a shipping crisis in the Gulf region creates a bottleneck for essential components. Microprocessors, batteries, and other critical parts that form the backbone of smartphone, laptop, and appliance production are arriving late and at higher costs, forcing companies to

The Centre has rejected a Bloomberg Economics analysis that suggested the Reserve Bank of India may have sold gold reserves to bolster the country’s foreign-currency assets. The Bloomberg Economics report estimated that the RBI likely sold around $12 billion worth of gold in the two weeks through May 22 while purchasing roughly $7.5 billion in

For at least a decade, India’s domestic institutional investors largely stayed away from Rajesh Exports. Mutual funds, which held a peak stake of just 0.5% in March 2016, have since exited completely. Private insurance companies hold no meaningful exposure either. LIC took a different view. The state-owned insurer increased its stake more than fivefold, from

India’s government has taken a controversial step to address severe shortages of two critical cancer drugs by approving price increases for cisplatin and carboplatin. The Centre granted in-principle approval using special powers under Para 19 of the Drugs Price Control Order, or DPCO. This move allows manufacturers to raise prices, with final numbers to be